“Ofatumumab: A Second Generation Anti-CD20 Monoclonal Antibody in Chronic Lymphocytic Leukemia”. 2009. Hematology Meeting Reports (formerly Haematologica Reports) 3 (3). https://doi.org/10.4081/hmr.v3i3.583.